Allergy
Latest News
FDA Greenlights Dupilumab for Chronic Spontaneous Urticaria, Marking First Approval in a Decade
Complete Responses Seen With Emerging Therapies for Chronic Spontaneous Urticaria
Significant Disease Burden and Management Issues in Chronic Spontaneous Urticaria
Genetics and Environment Both Play a Role in Childhood Allergy Progression
Patient Education, Provider Education, and Overall Final Thoughts
Navigating New Frontiers: Bruton Tyrosine Kinase Inhibitors in Chronic Spontaneous Urticaria Treatment
The Evaluation of Dupilumab In Chronic Spontaneous Urticaria Treatment
Key Updates Needed in Chronic Spontaneous Urticaria Guidelines
Addressing Persistent Symptoms in Chronic Spontaneous Urticaria: Beyond IgE-Targeted Treatments
The Use of Systemic Corticosteroids In Chronic Spontaneous Urticaria Treatment
Approaches to Switching Between Antihistamines and Other Medications When Treating Patients with Chronic Spontaneous Urticaria
Therapies Typically Used in the Firstline For Patients With Chronic Spontaneous Urticaria
Healthcare Specialties Involved in Managing Patients With Chronic Spontaneous Urticaria
Differential Diagnosis When Considering Chronic Spontaneous Urticaria
